1. Hackshaw, A, Rodeck, C & Boniface, S (2011) Maternal smoking in pregnancy and birth defects: a systematic review based on 173687 malformed cases and 11·7 million controls. Hum Reprod Update 17, 589–604.
2. Ekblad, M, Korkeila, J & Lehtonen, L (2015) Smoking during pregnancy affects foetal brain development. Acta Paediatr 104, 12–18.
4. Chittleborough, CR, Lawlor, DA & Lynch, JW (2012) Prenatal prediction of poor maternal and offspring outcomes: implications for selection into intensive parent support programs. Matern Child Health J 16, 909–920.
5. Roelands, J, Jamison, MG, Lyerly, AD, et al. (2009) Consequences of smoking during pregnancy on maternal health. J Womens Health (Larchmt) 18, 867–872.
6. Hammoud, AO, Bujold, E, Sorokin, Y, et al. (2005) Smoking in pregnancy revisited: findings from a large population-based study. Am J Obstet Gynecol 192, 1856–1862 discussion 1862–1853.
7. Nabet, C, Ancel, PY, Burguet, A, et al. (2005) Smoking during pregnancy and preterm birth according to obstetric history: French national perinatal surveys. Paediatr Perinat Epidemiol 19, 88–96.
8. Ward, C, Lewis, S & Coleman, T (2007) Prevalence of maternal smoking and environmental tobacco smoke exposure during pregnancy and impact on birth weight: retrospective study using Millennium Cohort. BMC Public Health 7, 81.
9. Wisborg, K, Kesmodel, U, Henriksen, TB, et al. (2001) Exposure to tobacco smoke in utero and the risk of stillbirth and death in the first year of life. Am J Epidemiol 154, 322–327.
10. Leite, M, Albieri, V, Kjaer, SK, et al. (2014) Maternal smoking in pregnancy and risk for congenital malformations: results of a Danish register-based cohort study. Acta Obstet Gynecol Scand 93, 825–834.
11. Kayemba-Kay’s, S, Ribrault, A, Burguet, A, et al. (2010) Maternal smoking during pregnancy and fetal growth. Effects in preterm infants of gestational age less than 33 weeks. Swiss Med Wkly 140, w13139.
12. Haghighi, A, Schwartz, DH, Abrahamowicz, M, et al. (2013) Prenatal exposure to maternal cigarette smoking, amygdala volume, and fat intake in adolescence. JAMA Psychiatry 70, 98–105.
13. Bublitz, MH & Stroud, LR (2012) Maternal smoking during pregnancy and offspring brain structure and function: review and agenda for future research. Nicotine Tob Res 14, 388–397.
14. St Pourcain, B, Mandy, WP, Heron, J, et al. (2011) Links between co-occurring social-communication and hyperactive-inattentive trait trajectories. J Am Acad Child Adolesc Psychiatry 50, 892–902 e895.
15. Banerjee, TD, Middleton, F & Faraone, SV (2007) Environmental risk factors for attention-deficit hyperactivity disorder. Acta Paediatr 96, 1269–1274.
16. Froehlich, TE, Lanphear, BP, Auinger, P, et al. (2009) Association of tobacco and lead exposures with attention-deficit/hyperactivity disorder. Pediatrics 124, e1054–e1063.
17. Lindblad, F & Hjern, A (2010) ADHD after fetal exposure to maternal smoking. Nicotine Tob Res 12, 408–415.
18. Zhu, JL, Olsen, J, Liew, Z, et al. (2014) Parental smoking during pregnancy and ADHD in children: the Danish national birth cohort. Pediatrics 134, e382–e388.
19. Albuquerque, CA, Smith, KR, Johnson, C, et al. (2004) Influence of maternal tobacco smoking during pregnancy on uterine, umbilical and fetal cerebral artery blood flows. Early Hum Dev 80, 31–42.
20. Luck, W, Nau, H, Hansen, R, et al. (1985) Extent of nicotine and cotinine transfer to the human fetus, placenta and amniotic fluid of smoking mothers. Dev Pharmacol Ther 8, 384–395.
21. Williams, GM, O’Callaghan, M, Najman, JM, et al. (1998) Maternal cigarette smoking and child psychiatric morbidity: a longitudinal study. Pediatrics 102, e11.
22. Lyall, K, Schmidt, RJ & Hertz-Picciotto, I (2014) Maternal lifestyle and environmental risk factors for autism spectrum disorders. Int J Epidemiol 43, 443–464.
23. Muneoka, K, Ogawa, T, Kamei, K, et al. (2001) Nicotine exposure during pregnancy is a factor which influences serotonin transporter density in the rat brain. Eur J Pharmacol 411, 279–282.
24. Roy, TS & Sabherwal, U (1998) Effects of gestational nicotine exposure on hippocampal morphology. Neurotoxicol Teratol 20, 465–473.
25. Rabinovitz, S (2014) Effects of omega-3 fatty acids on tobacco craving in cigarette smokers: A double-blind, randomized, placebo-controlled pilot study. J Psychopharmacol 28, 804–809.
26. Zaparoli, JX & Galduroz, JC (2012) Treatment for tobacco smoking: a new alternative? Med Hypotheses 79, 867–868.
27. Salem, N Jr. & Niebylski, CD (1995) The nervous system has an absolute molecular species requirement for proper function. Mol Membr Biol 12, 131–134.
28. Zaparoli, JX, Sugawara, EK, de Souza, AA, et al. (2016) Omega-3 Levels and Nicotine Dependence: A Cross-Sectional Study and Clinical Trial. Eur Addict Res 22, 153–162.
29. Boyd, A, Golding, J, Macleod, J, et al. (2013) Cohort Profile: the ‘children of the 90s’--the index offspring of the Avon Longitudinal Study of Parents and Children. Int J Epidemiol 42, 111–127.
30. Golding, J, Pembrey, M, Jones, R, et al. (2001) ALSPAC--the Avon Longitudinal Study of Parents and Children. I. Study methodology. Paediatr Perinat Epidemiol 15, 74–87.
31. Hibbeln, JR, Davis, JM, Steer, C, et al. (2007) Maternal seafood consumption in pregnancy and neurodevelopmental outcomes in childhood (ALSPAC study): an observational cohort study. Lancet 369, 578–585.
32. Food Standards Agency (2008) McCance & Widdowson’s Composition of Foods Integrated Dataset (CoF IDS) McCance and Widdowson’s The Composition of Foods Series
. London: Food Standards Agency.
33. Coleman, T, Chamberlain, C, Davey, MA, et al. (2012) Pharmacological interventions for promoting smoking cessation during pregnancy. Cochrane Database Syst Rev, issue 9, CD010078.
34. Koob, GF & Volkow, ND (2016) Neurobiology of addiction: a neurocircuitry analysis. Lancet Psychiatry 3, 760–773.
35. Ahmad, SO, Park, JH, Radel, JD, et al. (2008) Reduced numbers of dopamine neurons in the substantia nigra pars compacta and ventral tegmental area of rats fed an n-3 polyunsaturated fatty acid-deficient diet: a stereological study. Neurosci Lett 438, 303–307.
36. Chalon, S (2006) Omega-3 fatty acids and monoamine neurotransmission. Prostaglandins Leukot Essent Fatty Acids 75, 259–269.
37. Zimmer, L, Delion-Vancassel, S, Durand, G, et al. (2000) Modification of dopamine neurotransmission in the nucleus accumbens of rats deficient in n-3 polyunsaturated fatty acids. J Lipid Res 41, 32–40.
38. Zimmer, L, Delpal, S, Guilloteau, D, et al. (2000) Chronic n-3 polyunsaturated fatty acid deficiency alters dopamine vesicle density in the rat frontal cortex. Neurosci Lett 284, 25–28.
39. Alvheim, AR, Malde, MK, Osei-Hyiaman, D, et al. (2012) Dietary linoleic acid elevates endogenous 2-AG and anandamide and induces obesity. Obesity (Silver Spring) 20, 1984–1994.
40. Ramsden, CE, Zamora, D, Makriyannis, A, et al. (2015) Diet-induced changes in n-3- and n-6-derived endocannabinoids and reductions in headache pain and psychological distress. J Pain 16, 707–716.
41. Cao, D, Kevala, K, Kim, J, et al. (2009) Docosahexaenoic acid promotes hippocampal neuronal development and synaptic function. J Neurochem 111, 510–521.
42. Cao, D, Xue, R, Xu, J, et al. (2005) Effects of docosahexaenoic acid on the survival and neurite outgrowth of rat cortical neurons in primary cultures. J Nutr Biochem 16, 538–546.
43. Hibbeln, JR, Bissette, G, Umhau, JC, et al. (2004) Omega-3 status and cerebrospinal fluid corticotrophin releasing hormone in perpetrators of domestic violence. Biol Psychiatry 56, 895–897.
44. Song, C, Zhang, XY & Manku, M (2009) Increased phospholipase A2 activity and inflammatory response but decreased nerve growth factor expression in the olfactory bulbectomized rat model of depression: effects of chronic ethyl-eicosapentaenoate treatment. J Neurosci 29, 14–22.
45. Brenna, JT & Diau, GY (2007) The influence of dietary docosahexaenoic acid and arachidonic acid on central nervous system polyunsaturated fatty acid composition. Prostaglandins Leukot Essent Fatty Acids 77, 247–250.
46. Diau, GY, Hsieh, AT, Sarkadi-Nagy, EA, et al. (2005) The influence of long chain polyunsaturated supplementation on docosahexaenoic acid and arachidonic acid in baboon neonate central nervous system. BMC Med 3, 11.
47. Carlson, SE (2001) Docosahexaenoic acid and arachidonic acid in infant development. Semin Neonatol 6, 437–449.
48. Buydens-Branchey, L, Branchey, M & Hibbeln, JR (2008) Associations between increases in plasma n-3 polyunsaturated fatty acids following supplementation and decreases in anger and anxiety in substance abusers. Prog Neuropsychopharmacol Biol Psychiatry 32, 568–575.
49. Buydens-Branchey, L, Branchey, M, McMakin, DL, et al. (2003) Polyunsaturated fatty acid status and aggression in cocaine addicts. Drug Alcohol Depend 71, 319–323.
50. Conklin, SM, Manuck, SB, Yao, JK, et al. (2007) High omega-6 and low omega-3 fatty acids are associated with depressive symptoms and neuroticism. Psychosom Med 69, 932–934.
51. Hibbeln, JR (2009) Depression, suicide and deficiencies of omega-3 essential fatty acids in modern diets. World Rev Nutr Diet 99, 17–30.
52. Scaglia, N, Chatkin, J, Chapman, KR, et al. (2016) The relationship between omega-3 and smoking habit: a cross-sectional study. Lipids Health Dis 15, 61.